Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis after Hypoxic-Ischemic Brain Damage in Neonatal Rats

PLoS One. 2015 Jul 14;10(7):e0132998. doi: 10.1371/journal.pone.0132998. eCollection 2015.

Abstract

c-Jun N-terminal kinase (JNK) plays a key role in the regulation of neuronal apoptosis. Previous studies have revealed that forkhead transcription factor (FOXO3a) is a critical effector of JNK-mediated tumor suppression. However, it is not clear whether the JNK/FOXO3a pathway is involved in neuronal apoptosis in the developing rat brain after hypoxia-ischemia (HI). In this study, we generated an HI model using postnatal day 7 rats. Fluorescence immunolabeling and Western blot assays were used to detect the distribution and expression of total and phosphorylated JNK and FOXO3a and the pro-apoptotic proteins Bim and CC3. We found that JNK phosphorylation was accompanied by FOXO3a dephosphorylation, which induced FOXO3a translocation into the nucleus, resulting in the upregulation of levels of Bim and CC3 proteins. Furthermore, we found that JNK inhibition by AS601245, a specific JNK inhibitor, significantly increased FOXO3a phosphorylation, which attenuated FOXO3a translocation into the nucleus after HI. Moreover, JNK inhibition downregulated levels of Bim and CC3 proteins, attenuated neuronal apoptosis and reduced brain infarct volume in the developing rat brain. Our findings suggest that the JNK/FOXO3a/Bim pathway is involved in neuronal apoptosis in the developing rat brain after HI. Agents targeting JNK may offer promise for rescuing neurons from HI-induced damage.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Acetonitriles / pharmacology
  • Active Transport, Cell Nucleus / drug effects
  • Animals
  • Animals, Newborn
  • Apoptosis Regulatory Proteins / metabolism*
  • Apoptosis* / drug effects
  • Bcl-2-Like Protein 11
  • Benzothiazoles / pharmacology
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Female
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors / metabolism*
  • Gene Expression Regulation, Enzymologic / drug effects
  • Hypoxia-Ischemia, Brain / metabolism
  • Hypoxia-Ischemia, Brain / pathology*
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • MAP Kinase Signaling System* / drug effects
  • Male
  • Membrane Proteins / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology*
  • Phosphoproteins / metabolism
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation / drug effects

Substances

  • 1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile
  • Acetonitriles
  • Apoptosis Regulatory Proteins
  • Bcl-2-Like Protein 11
  • Bcl2l11 protein, rat
  • Benzothiazoles
  • FOXO3 protein, rat
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors
  • Membrane Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • JNK Mitogen-Activated Protein Kinases

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 81000262 to Deyuan Li, No. 81330016 and 31171020 to Dezhi Mu; No. 81172174 and 81270724 to Yi Qu, No. 81100457 to Jinhui Li, and No. 81200462 to Li Zhang), the Major State Basic Research Development Program (2013CB967404), grants from the Ministry of Education of China (313037, 20110181130002), a grant from the State Commission of Science Technology of China (2012BAI04B04), grants from the Science and Technology Bureau of Sichuan province (2010SZ0280, 2011JTD0005, 2012SZ0150), and the Grant of Clinical Discipline Program (Neonatology) from the Ministry of Health of China (1311200003303).